Archive for: March 2008

AFP - Just 48 hours of fasting was enough to protect mice from the side effects of an intensive chemotherapy treatment which wiped out much of the cancer in their bodies, according to a study published Monday.

AFP - Just 48 hours of fasting was enough to protect mice from the side effects of an intensive chemotherapy treatment which wiped out much of the cancer in their bodies, according to a study published Monday.

HealthDay - TUESDAY, March 25 (HealthDay News) -- Magnetic resonance imaging (MRI) can help predict the risk of cancer recurrence in prostate cancer patients who are about to have radiation therapy, a new U.S. study says.

HealthDay - TUESDAY, March 25 (HealthDay News) -- Magnetic resonance imaging (MRI) can help predict the risk of cancer recurrence in prostate cancer patients who are about to have radiation therapy, a new U.S. study says.

AP - One of the first large quality-of-life studies on today's prostate cancer treatments suggests that for some men, it's a matter of picking your poison and facing potential sexual, urinary or other problems.

HealthDay - WEDNESDAY, March 19 (HealthDay News) -- Quality-of-life issues should be weighed carefully when prostate cancer patients are considering the thicket of treatment options available to them, new research suggests.

Reuters - Age, race and obesity affect how satisfied men are with their treatment for prostate cancer, U.S. researchers said on Wednesday.

HealthDay - TUESDAY, March 18 (HealthDay News) -- Freezing the prostate to kill cancer, a procedure called cryotherapy, may be as effective as more common treatments such as radiation, U.S. researchers report in the first such follow-up study spanning 10 years.

HealthDay - TUESDAY, March 11 (HealthDay News) -- Chemotherapy following surgery does not improve survival in stomach cancer patients, says an Italian study.

HealthDay - MONDAY, March 10 (HealthDay News) -- Changes in medical practice have undermined the value of the prostate-specific antigen (PSA) test as a diagnostic tool for prostate cancer, a new study asserts.